×
About 215 results

ALLMedicine™ Cavernous Sinus Thrombosis Center

Research & Reviews  82 results

Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-...
https://doi.org/10.1097/IOP.0000000000002112
Ophthalmic Plastic and Reconstructive Surgery; Goel R, Arora R et. al.

Dec 18th, 2021 - To correlate the clinical, radiological, and histopathological features in Covid-associated Rhino-orbito-cerebral mucormycosis cases presenting with acute visual loss. Cross-sectional study. Covid-associated Rhino-orbito-cerebral mucormycosis case...

Different causes and diverse outcomes of extremely rare septic cavernous sinus thrombos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493721
European Journal of Medical Research; Chen BA, Liu ZH et. al.

Oct 8th, 2021 - Cases of acute sphenoid sinusitis complicated by septic cavernous sinus (CS) thrombosis and internal carotid artery (ICA) stenosis are rarely reported. Different causative pathogens have been reported for this condition. We present two extremely r...

A new pattern of cranial nerve injuries caused by unfavorable fractures during Le Fort ...
https://doi.org/10.1016/j.jormas.2021.09.006
Journal of Stomatology, Oral and Maxillofacial Surgery; Gaspar C, Santos RB et. al.

Sep 14th, 2021 - Cranial nerve injury is a described complication of Le Fort I osteotomy technique. The authors present the case of a 45-year-old patient that underwent bimaxillary orthognathic surgery and suffered unfavorable skull base fractures, which resulted ...

Cavernous Sinus Thrombosis
https://www.merckmanuals.com/professional/eye-disorders/orbital-diseases/cavernous-sinus-thrombosis

Aug 1st, 2021 - Cavernous sinus thrombosis is a very rare, typically septic thrombosis of the cavernous sinus, usually caused by nasal furuncles or bacterial sinusitis. Symptoms and signs include pain, proptosis, ophthalmoplegia, vision loss, papilledema, and fev...

Cavernous Sinus Thrombosis
https://www.merckmanuals.com/en-ca/professional/eye-disorders/orbital-diseases/cavernous-sinus-thrombosis

Aug 1st, 2021 - Cavernous sinus thrombosis is a very rare, typically septic thrombosis of the cavernous sinus, usually caused by nasal furuncles or bacterial sinusitis. Symptoms and signs include pain, proptosis, ophthalmoplegia, vision loss, papilledema, and fev...

see more →

News  4 results

Candida auris Tied to Vision Loss in Case Report
https://www.medscape.com/viewarticle/917986

Sep 9th, 2019 - Infection with Candida auris likely led to panophthalmitis and vision loss in an immune compromised patient, according to a case report published online today in the Annals of Internal Medicine. Vinayak Shenoy, DO, and colleagues at Lenox Hill Hos...

Novel Hemophilia A Treatments Advance
https://www.medpagetoday.com/hematologyoncology/hemophilia/66523

Jul 10th, 2017 - The novel monoclonal antibody emicizumab substantially reduced bleeding risk in adolescents and adults with hemophilia A who have developed an immune response against standard factor VIII treatment, the phase III HAVEN trial showed. The drug, whic...

Prophylactic emicizumab cut bleeds by 87% in hemophilia A with inhibitors
https://www.mdedge.com/familymedicine/article/142113/bleeding-disorders/prophylactic-emicizumab-cut-bleeds-87-hemophilia
Hematology News; Amy Karon

Jul 10th, 2017 - Once-weekly prophylactic therapy with emicizumab (ACE910) was associated an 87% lower rate of treated bleeding than no prophylaxis among patients with hemophilia A with inhibitors in the open-label, phase III HAVEN 1 trial. After a median 24 weeks.

Prophylactic emicizumab cut bleeds by 87% in hemophilia A with inhibitors
https://www.mdedge.com/pediatrics/article/142113/bleeding-disorders/prophylactic-emicizumab-cut-bleeds-87-hemophilia
Amy Karon

Jul 10th, 2017 - Once-weekly prophylactic therapy with emicizumab (ACE910) was associated an 87% lower rate of treated bleeding than no prophylaxis among patients with hemophilia A with inhibitors in the open-label, phase III HAVEN 1 trial. After a median 24 weeks.

see more →